论文部分内容阅读
目的:探讨慢性肝炎采取复方甘草酸苷和异甘草酸镁治疗的疗效。方法:选取80例于2012年7月至2013年7月期间我院接收的慢性肝炎患者,将入选者平分为对照组与实验组,两组分别采取复方甘草酸苷和异甘草酸镁治疗,观察两组疗效。结果:治疗后,实验组较对照组的肝功能指标改善程度更显著(P<0.05),同时在疗效上,实验组相对更优(P<0.05),治疗期间未出现不良反应。结论:异甘草酸镁相比于复方甘草酸苷的疗效及安全性更高,值得推广。
Objective: To investigate the efficacy of compound glycyrrhizin and magnesium isoglycyrrhizinate in chronic hepatitis. Methods: Eighty patients with chronic hepatitis received in our hospital from July 2012 to July 2013 were divided equally into the control group and the experimental group. The two groups were treated with compound glycyrrhizin and magnesium isoglycyrrhizinate respectively. Two groups Efficacy. Results: After treatment, the improvement of liver function indexes in the experimental group was more significant than that in the control group (P <0.05). At the same time, the experimental group was superior to the experimental group (P <0.05) and no adverse reaction occurred during the treatment. Conclusion: Glycyrrhizin is more effective and safe than compound glycyrrhizin and should be widely used.